If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hideya Ohnishi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Neoplasms Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Monocytes Medicine & Life Sciences
Regulatory T-Lymphocytes Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 1536 Citations
  • 24 h-Index
  • 80 Article
  • 8 Review article
  • 1 Chapter
  • 1 Comment/debate

Liprin-α4 as a new therapeutic target for SCLC as an upstream mediator of HIF1α

Ohnishi, H., Yamasaki, A., Nakamura, K., Ichimiya, S., Yanai, K., Umebayashi, M., Nagai, S. & Morisaki, T., Mar 1 2019, In : Anticancer research. 39, 3, p. 1179-1184 6 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Cell Hypoxia
Cisplatin
CD45 Antigens
Hypoxia-Inducible Factor 1
1 Citation (Scopus)

Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma

Nakamura, S., Sadakari, Y., Takao, O., Okayama, T., Nakashima, Y., Gotoh, Y., Saeki, K., Mori, Y., Nakata, K., Miyasaka, Y., Ohnishi, H., Oda, Y., Goggins, M. & Nakamura, M., Jul 15 2019, In : Annals of Surgical Oncology. 26, 7, p. 2104-2111 8 p.

Research output: Contribution to journalArticle

Pancreatic Juice
MicroRNAs
Adenocarcinoma
Biomarkers
Exosomes
1 Citation (Scopus)

Catumaxomab with activated T-cells efficiently lyses chemoresistant EpCAM-positive triple-negative breast cancer cell lines

Kubo, M., Umebayashi, M., Kurata, K., Mori, H., Kai, M., Ohnishi, H., Katano, M., Nakamura, M. & Morisaki, T., Jul 1 2018, In : Anticancer Research. 38, 7, p. 4273-4279 7 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
T-Lymphocytes
Cell Line
Breast Neoplasms
Bispecific Antibodies
4 Citations (Scopus)

Combined gemcitabine and metronidazole is a promising therapeutic strategy for cancer stem-like cholangiocarcinoma

Kawamoto, M., Umebayashi, M., Tanaka, H., Koya, N., Nakagawa, S., Kawabe, K., Ohnishi, H., Nakamura, M. & Morisaki, T., May 1 2018, In : Anticancer research. 38, 5, p. 2739-2748 10 p.

Research output: Contribution to journalArticle

gemcitabine
Cholangiocarcinoma
Metronidazole
Aldehyde Dehydrogenase
Neoplasms
1 Citation (Scopus)

RBPJ and MAML3: Potential therapeutic targets for small cell lung cancer

Ohnishi, H., Ichimiya, S., Yanai, K., Umebayashi, M., Nakamura, K., Yamasaki, A., Imaizumi, A., Nagai, S., Murahashi, M., Ogata, H. & Morisaki, T., Aug 1 2018, In : Anticancer research. 38, 8, p. 4543-4547 5 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
gemcitabine
Therapeutics
Matrix Metalloproteinases
Pancreatic Neoplasms